Despite HPV vaccines, screening will remain central for decades to control cervical cancer.
Recently, HPV testing alone or with cytology was introduced as an alternative to cytology …

Objective Thirteen human papillomavirus (HPV) genotypes are associated with the highest
risk of cervical disease/cancer; however, the risk of disease progression and cancer is …

Rebecca B. Perkins, MD, MSc, 1 Richard S. Guido, MD, 2 Philip E. Castle, PhD, 3 David
Chelmow, MD, 4 Mark H. Einstein, MD, MS, 5 Francisco Garcia, MD, MPH, 6 Warner K. Huh …

Background Meta-analyses have become an essential tool in synthesizing evidence on
clinical and epidemiological questions derived from a multitude of similar studies assessing …

The control arm of the phase III VIVIANE (Human PapillomaVIrus: Vaccine Immunogenicity
ANd Efficacy; NCT00294047) study in women> 25 years was studied to assess risk of …

Procedures combining and summarising direct and indirect evidence from independent
studies assessing the diagnostic accuracy of different tests for the same disease are referred …

Background Women with atypical squamous cells of undetermined significance (ASC‐US)
can be triaged accurately with a high‐risk human papillomavirus (hrHPV) test to identify …

Background: High-risk human papillomavirus (hrHPV) testing to triage women with minor
cervical lesions generates many referrals. Purpose: To evaluate the accuracy of genotyping …

Management algorithms for screen‐positive women in cervical cancer prevention programs
have undergone substantial changes in recent years. The WHO strongly recommends …

Background Cervical cancer can be prevented by early detection and treatment for
precancerous lesions. Since 1995, there has been a national cervical cancer screening …